Annunziata Gloghini

Annunziata Gloghini's AcademicInfluence.com Rankings

Annunziata Gloghini

Biology

#13180

World Rank

#16712

Historical Rank

Biotechnology

#240

World Rank

#242

Historical Rank

Molecular Biology

#2198

World Rank

#2232

Historical Rank

biology Degrees

Download Badge

Biology

Annunziata Gloghini's Degrees

PhD Biomedical Sciences University of Milan
Masters Biotechnology University of Milan
Bachelors Biotechnology University of Milan

Why Is Annunziata Gloghini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Annunziata Gloghini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

HIV-associated lymphomas and gamma-herpesviruses. (2009) (329)
Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. (2002) (305)
EBV-associated lymphoproliferative disorders: classification and treatment. (2008) (285)
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. (2003) (260)
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape (2010) (254)
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. (2001) (246)
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. (2003) (242)
Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. (2000) (242)
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. (1995) (229)
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. (1997) (220)
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. (2007) (219)
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. (2000) (219)
Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions (1996) (206)
Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. (1995) (200)
The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. (1998) (181)
AIDS‐related lymphomas: from pathogenesis to pathology (2005) (180)
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. (1995) (169)
Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions (2008) (153)
Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. (1998) (148)
CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. (1995) (147)
Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. (2005) (142)
Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. (1998) (140)
Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. (1997) (139)
KSHV/HHV8‐associated lymphomas (2007) (133)
Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. (1996) (131)
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer (2016) (131)
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. (2003) (130)
Molecular histogenesis of posttransplantation lymphoproliferative disorders. (2003) (121)
Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. (1993) (117)
Pre‐malignant and malignant lymphoproliferations in an HCV‐infected type II mixed cryoglobulinemic patient are sequential phases of an antigen‐driven pathological process (2000) (117)
Diagnosis and management of lymphomas and other cancers in HIV-infected patients (2014) (116)
CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. (1997) (115)
Genetic characterization of HHV‐8/KSHV–positive primary effusion lymphoma reveals frequent mutations of BCL6: Implications for disease pathogenesis and histogenesis (1999) (113)
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. (1997) (110)
Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. (1997) (109)
Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia (1996) (106)
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. (2004) (105)
Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. (2013) (103)
Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. (1990) (103)
Atrophic Gastritis and Intestinal Metaplasia in Helicobacter pylori Infection: The role of CagA status (1998) (102)
The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. (1995) (97)
Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease (2002) (96)
Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production (2017) (94)
A lymphomagenic role for HIV beyond immune suppression? (2016) (94)
Review of Sinus Histiocytosis with Massive Lymphadenopathy (Rosai-Dorfman Disease) of Head and Neck (1999) (92)
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. (2006) (92)
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low‐grade lymphoma associated with autoimmune disease and in chronic gastritis (2000) (92)
HIV-associated Hodgkin lymphoma. (2009) (91)
Clinicopathological Consultation Aids-Related Plasmablastic Lymphomas of the Oral Cavity and Jaws: A Diagnostic Dilemma (1999) (90)
Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain (1995) (88)
Establishment and characterization of EBV‐positive and EBV‐negative primary effusion lymphoma cell lines harbouring human herpesvirus type‐8 (1998) (87)
Molecular histogenesis of plasmablastic lymphoma of the oral cavity (2002) (87)
Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. (1999) (85)
A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy (1991) (84)
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b (2015) (82)
Functional coexpression of Interleukin (IL)‐7 and its receptor (IL‐7R) on Hodgkin and Reed‐Sternberg cells: Involvement of IL‐7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma (2009) (82)
Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. (1994) (82)
AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens. (1995) (81)
Burkitt's lymphoma in adults with and without human immunodeficiency virus infection (1998) (81)
Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. (2001) (81)
Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors (2009) (81)
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas (1999) (78)
CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. (1996) (77)
Establishment of HHV‐8‐positive and HHV‐8‐negative lymphoma cell lines from primary lymphomatous effusions (1997) (77)
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer. (2016) (76)
Simian‐virus‐40 footprints in human lymphoproliferative disorders of HIV− and HIV+ patients (1998) (74)
TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. (2006) (74)
HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research (2016) (72)
Isolating p16-positive/HPV-negative oropharyngeal cancer: an effort worth making. (2011) (71)
Follicular lymphoma (2019) (70)
miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. (2016) (70)
BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. (1997) (69)
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study (2017) (68)
CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lym (1995) (68)
HIV-associated human herpesvirus 8-positive primary lymphomatous effusions: radiologic findings in six patients. (1997) (67)
The role of eosinophils in the pathobiology of Hodgkin's disease. (1997) (66)
Molecular profile of Epstein–Barr virus infection in HHV-8-positive primary effusion lymphoma (2000) (66)
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control study (2017) (64)
B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. (2010) (64)
Pathological Features of Lymphoid Proliferations of the Salivary Glands: Lymphoepithelial Sialadenitis versus Low-Grade B-Cell Lymphoma of the Malt Type (2000) (64)
Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. (1997) (63)
KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas. (1995) (61)
PEL and HHV8‐unrelated effusion lymphomas (2008) (58)
First‐line therapy with dacomitinib, an orally available pan‐HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open‐label, single‐arm, single‐centre, phase 2 study (2018) (58)
Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells. (2002) (58)
Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. (2010) (56)
Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study. (1996) (55)
Genome wide DNA‐profiling of HIV‐related B‐cell lymphomas (2010) (55)
Plasma HHV‐8 viral load in HHV‐8‐related lymphoproliferative disorders associated with HIV infection (2009) (52)
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. (2005) (52)
Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. (2003) (52)
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis. (2002) (52)
Hodgkin's Disease in Patients with HIV Infection (2010) (51)
KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype (2005) (51)
CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues. (1997) (49)
Delineation of HER2 gene status in breast carcinoma by silver in situ hybridization is reproducible among laboratories and pathologists. (2008) (49)
The tyrosine kinase receptor Met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma (2000) (49)
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy (2014) (49)
Frequent aberrant promoter hypermethylation of O6‐methylguanine‐DNA methyltransferase and death‐associated protein kinase genes in immunodeficiency‐related lymphomas (2003) (48)
Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection. (2004) (48)
The Germinal centre‐derived lymphomas seen through their cellular microenvironment (2009) (47)
RT-PCR analysis of RNA extracted from Bouin-fixed and paraffin-embedded lymphoid tissues. (2004) (46)
Histopathologic, immunophenotypic, and genotypic analysis of Ki‐1 anaplastic large cell lymphomas that express histiocyte‐associated antigens (1990) (46)
Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy (2019) (46)
Non‐Hodgkin's lymphoma in the elderly I. Pathologic features at presentation (1990) (46)
High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large‐cell ki‐1‐positive lymphomas in HIV‐1‐positive patients (1993) (45)
Role of cMET in the Development and Progression of Colorectal Cancer (2013) (45)
TuBaFrost 1: Uniting local frozen tumour banks into a European network: an overview. (2006) (44)
The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis (2017) (44)
BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas (1997) (44)
Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome. (1995) (44)
The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment (2012) (43)
Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. (1997) (43)
AIDS-related extranodal non-Hodgkin's lymphomas with plasma cell differentiation. (1997) (43)
Efficacy of CT-guided percutaneous needle biopsy in the diagnosis of malignant lymphoma at first presentation. (2005) (43)
The Coincidence of Chromosome 15 Aberrations and β2-Microglobulin Gene Mutations Is Causative for the Total Loss of Human Leukocyte Antigen Class I Expression in Melanoma (2006) (42)
Demonstration of Epstein-Barr viral genomes by in situ hybridization in acquired immune deficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas. (1993) (41)
Vimentin immunostaining in fibroblastic reticulum cells within human reactive and neoplastic lymphoid follicles. (1990) (41)
Reed-Sternberg Cells of Classical Hodgkin's Disease React With the Plasma Cell-Specific Monoclonal Antibody B-B4 and Express Human Syndecan-1 (1997) (40)
Spontaneous T cell responses to Epstein‐Barr virus‐encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: Bases for improved immunotherapy (2008) (40)
A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin (2006) (39)
Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21. (1997) (39)
Plasmablastic lymphoma: One or more entities? (2008) (39)
CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. (1994) (39)
Molecular mechanisms possibly affecting WT1 function in human ovarian tumors (1994) (39)
Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and ‘jumping translocations’ of 1q in a human immunodeficiency virus‐related non‐Hodgkin's lymphoma (1995) (39)
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature. (2010) (38)
Expression of protectin (CD59) in human melanoma and its functional role in cell‐ and complement‐mediated cytotoxicity (1995) (38)
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients. (2018) (38)
Detection of BCL‐6 rearrangements and p53 mutations in malt‐lymphomas (1997) (37)
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma (2000) (37)
Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. (2000) (37)
High Frequency of Epstein-Barr Virus Latent Membrane Protein-1 Expression in Acquired Immunodeficiency Syndrome-related Ki-l (CD30)-positive Anaplastic Large-cell Lymphomas (1994) (37)
KP1 (CD68)-positive large cell lymphomas: a histopathologic and immunophenotypic characterization of 12 cases. (1993) (37)
MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. (1995) (37)
Point mutations of the BCL‐6 gene in Burkitt's lymphoma (1997) (36)
PROLIFERATION IN HHV‐8 POSITIVE PRIMARY EFFUSION LYMPHOMAS IS ASSOCIATED WITH EXPRESSION OF HHV‐8 CYCLIN BUT INDEPENDENT OF P27/KIP1: ABSTRACT 39 (2000) (36)
Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis (2000) (36)
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition. (2019) (36)
Primary Effusion Lymphoma Cell Lines Harbouring Human Herpesvirus Type-8 (2000) (36)
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. (2006) (36)
The role of interleukin-3 in classical Hodgkin's disease (2005) (36)
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis. (2014) (35)
Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia. (1997) (35)
Mixed renal tumor with carcinomatous and fibroleiomyomatous components, associated with angiomyolipoma in the same kidney. (1993) (34)
MIF/CD74 axis is a target for novel therapies in colon carcinomatosis (2017) (34)
Immunohistochemistry of hodgkin and non‐hodgkin lymphomas with emphasis on the diagnostic significance of the BNHS antibody reactivity with anaplastic large cell (CD30 positive) lymphomas (1992) (34)
Primary refractory and early‐relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment (2015) (34)
KSHV‐associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies (2015) (34)
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? (2018) (33)
Genetic pathways and histogenetic models of AIDS-related lymphomas. (2001) (33)
Aberrant somatic hypermutation in post‐transplant lymphoproliferative disorders (2004) (33)
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand. (2006) (32)
Classical Hodgkin's lymphoma arising in different host's conditions: Pathobiology parameters, therapeutic options, and outcome (2011) (32)
The role of inflammation in lymphoma. (2014) (32)
Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease. (1993) (31)
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma. (2011) (31)
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer. (2011) (31)
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study (2016) (31)
Human herpesvirus 6 in human immunodeficiency virus‐infected individuals: Association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders (1996) (31)
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas. (2008) (31)
Expression of Leu‐8 surface antigen in B‐cell lymphomas. Correlation with other B‐cell markers (1988) (31)
Differential expression of cell adhesion molecules in b‐zone small lymphocytic lymphoma and other well‐differentiated lymphocytic disorders (1993) (31)
Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. (1995) (31)
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score. (2008) (31)
Simian Virus 40 Sequences in Human Lymphoblastoid B-Cell Lines (2003) (30)
Molecular characterization of HHV-8 positive primary effusion lymphoma reveals pathogenetic and histogenetic features of the disease. (2000) (30)
TuBaFrost 6: virtual microscopy in virtual tumour banking. (2006) (30)
Heterogeneous in situ immunophenotyping of follicular dendritic reticulum cells in malignant lymphomas of B‐cell origin (1987) (30)
HHV-8-Associated Lymphoma: State-of-the-Art Review (2006) (30)
Analysis of human herpesvirus type 8 infection in AIDS-related and AIDS-unrelated primary central nervous system lymphoma. (1997) (30)
Hodgkin and Reed–Sternberg cells express functional c‐kit receptors and interact with primary fibroblasts from Hodgkin's disease‐involved lymph nodes through soluble and membrane‐bound stem cell factor (2002) (30)
The nonlymphoid microenvironment of reactive follicles and lymphomas of follicular origin as defined by immunohistology on paraffin-embedded tissues. (1993) (30)
The Role of Cytokines in the Pathogenesis and Management of Aids-Related Lymphomas (2000) (30)
Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy. (2005) (29)
Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin’s lymphoma reveals implications for disease pathogenesis and histogenesis (2008) (29)
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma (2002) (29)
Monocytoid B-cell lymphoma with bone marrow and peripheral blood involvement at presentation. (1989) (28)
B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders. (1992) (28)
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. (2004) (28)
Analysis of aberrant somatic hypermutation (SHM) in non‐Hodgkin's lymphomas of patients with chronic HCV infection (2005) (28)
Analysis of immunoglobulin heavy and light chain variable genes in post‐transplant lymphoproliferative disorders (2006) (28)
Patterns of cytokine expression in AIDS‐related non‐Hodgkin's lymphoma (1998) (28)
Lack of Hcv Infection in Malignant, Cells Refutes the Hypothesis of a Direct Transforming Action of the Virus in the Pathogenesis of Hcv-Associated B-Cell Nhls (2002) (28)
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area (2017) (28)
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma (2005) (27)
Why would the incidence of HIV‐associated Hodgkin lymphoma increase in the setting of improved immunity? (2007) (27)
TuBaFrost 5: multifunctional central database application for a European tumor bank. (2006) (27)
Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? (2004) (27)
In situ follicular lymphoma: pathologic characteristics and diagnostic features (2012) (27)
Analysis of the p53 gene in relation to tobacco and alcohol in cancers of the upper aero‐digestive tract (1995) (26)
Subtypes of epstein‐barr virus in HIV‐1‐associated and HIV‐1‐unrelated hodgkin's disease cases (1993) (26)
Epstein Barr Virus-Associated Hodgkin Lymphoma (2018) (26)
Microsatellite instability in KSHV/HHV-8 positive body-cavity-based lymphoma. (1997) (26)
Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue (2003) (26)
DIFFERENTIAL EXPRESSION OF BCL-6, CD 138/SYNDECAN-1 AND EBV-ENCODED LATENT MEMBRANE PROTEIN-1 IDENTIFIES DISTINCT HISTOGENETIC SUBSETS OF AIDS-RELATED NON-HODGKIN'S LYMPHOMAS. (1998) (26)
Epstein–Barr virus associated lymphomas in people with HIV (2017) (26)
High frequency of EBV association with non‐random abnormalities of the chromosome region 1q21‐25 in aids‐related Burkitt's lymphoma‐derived cell lines (1995) (26)
Report: workshop on mediastinal grey zone lymphoma (2005) (25)
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer (2017) (25)
Hepatitis C virus (HCV) infection and lymphoproliferative disorders (2005) (25)
AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation. (1996) (25)
Pigmented mammary Paget's disease mimicking melanoma (2004) (25)
CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease. (1995) (24)
The landscape of d16HER2 splice variant expression across HER2-positive cancers (2019) (24)
Association of Epstein-Barr Virus with Hodgkin’s Disease (1995) (23)
Dermatofibroma: Superficial fibrous proliferation with reactive histiocytes–a multiple immunostaining analysis (1994) (23)
TuBaFrost 4: access rules and incentives for a European tumour bank. (2006) (23)
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance (2007) (23)
Burkitt's Lymphoma: Historical Background and Recent Insights into Classification and Pathogenesis (2000) (22)
Herpesvirus-like DNA sequences selectively cluster with body cavity-based lymphomas throughout the spectrum of AIDS-related lymphomatous effusions. (1996) (22)
Castleman disease (2019) (21)
Hodgkin’s disease: A disorder of dysregulated cellular cross-talk (1998) (21)
Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas. (1996) (21)
Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis (2019) (21)
Basement membrane components in lymphoid follicles: immunohistochemical demonstration and relationship to the follicular dendritic cell network. (1989) (21)
Characteristics of EBV‐infected cells in HIV‐related lymphadenopathy: Implications for the pathogenesis of EBV‐associated and EBV‐unrelated lymphomas of HIV‐seropositive individuals (1995) (21)
IRF4 is modulated by CD40L and by apoptotic and anti‐proliferative signals in Hodgkin lymphoma (2010) (20)
Structural abnormality of 1q in an AIDS‐related body‐cavity‐based lymphoma (1996) (20)
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up (2019) (20)
Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. (2002) (20)
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes (2009) (20)
True identity by immunohistochemistry and molecular morphology of undifferentiated malignancies of the head and neck (2009) (20)
Differentiating germinal center‐derived lymphomas through their cellular microenvironment (2009) (19)
In situ follicular lymphoma associated with nonlymphoid malignancies (2012) (19)
Head and neck lymphomas associated with human immunodeficiency virus infection. (1995) (19)
Second Primary Lymphoma or Recurrence: A Dilemma Solved by VDJ Rearrangement Analysis (2004) (19)
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency‐related non‐Hodgkin lymphomas (2011) (19)
Follicular lymphoma of compartmentalized small cleaved center cells and mantle zone lymphocytes. Evidence for a common derivation. (1992) (19)
Genetic heterogeneity of AIDS‐related small non‐cleaved cell lymphoma (1997) (18)
Nodular lymphocyte predominant Hodgkin lymphoma with non‐invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcome (2013) (18)
Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry. (1995) (18)
LONG‐TERM SURVIVAL OF PATIENTS WITH HIV‐RELATED SYSTEMIC NON‐HODGKIN'S LYMPHOMAS (1996) (18)
Diagnostic significance of CD40, CD40L, and CD26 expression in Hodgkin's disease and other lymphomas. (1996) (17)
Virtual microscopy in virtual tumor banking. (2006) (17)
Alterations of negative regulators of cytokine signalling in immunodeficiency‐related non‐Hodgkin lymphoma (2013) (17)
CD40: a sensitive marker of Reed-Sternberg cells. (1996) (17)
4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas. (2015) (17)
Latent Membrane Protein 1 Deletion Mutants Accumulate in Reed-Sternberg Cells of Human Immunodeficiency Virus-Related Hodgkin's Lymphoma (2005) (17)
Coexisting follicular and mantle cell lymphoma with each having an in situ component. (2011) (17)
In situ follicular lymphoma associated with overt B‐ or T‐cell lymphomas in the same lymph node (2011) (17)
"Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease. (2012) (16)
Intrafollicular neoplasia/“in situ” lymphoma: A proposal for morphology and immunodiagnostic classification (2011) (16)
Hematological cancers in individuals infected by HIV. (2021) (16)
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. (1998) (16)
Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease (1999) (16)
BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas. (1997) (16)
Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications (2015) (16)
The Relevance of VDJ PCR Protocols in Detecting B-Cell Clonal Expansion in Lymphomas and Other Lymphoproliferative Disorders (1995) (16)
p53 protein over‐expression and p53 gene abnormalities in HIV‐1‐related non‐Hodgkin's lymphomas (1994) (15)
Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework (2016) (15)
A novel semi-automated in situ hybridisation protocol for microRNA detection in paraffin embedded tissue sections (2015) (15)
Emerging issues after the recognition of in situ follicular lymphoma (2014) (15)
Frequent mutation of bcl-6 proto-oncogene in high grade, but not low grade, MALT lymphomas of the gastrointestinal tract. (1999) (15)
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution Cohort. (2019) (15)
Ki-M6 immunostaining in routinely processed sections of reactive and neoplastic human lymphoid tissue. (1990) (15)
Differentiation between non‐Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis (2002) (14)
Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas (2005) (14)
A combined cytochemical and immunocytochemical method for simultaneous visualization of cytoplasmic enzyme reactivity and cell surface antigens in cell suspensions. (1989) (14)
In situ hybridization detection methods for HPV16 E6/E7 mRNA in identifying transcriptionally active HPV infection of oropharyngeal carcinoma: an updating. (2017) (14)
Follicular Dendritic Cell Pattern in Early Lymphomas Involving Follicles (2014) (14)
Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report (2007) (14)
Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1. (2002) (14)
High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants. (1997) (13)
Activated DDR1 increases RS cell survival. (2013) (13)
The value of immunohistochemistry in the diagnosis of soft tissue sarcomas. (1992) (13)
Association of 6q deletions with AIDS-related diffuse large cell lymphoma. (1996) (13)
Pathological and immunophenotypic features of adult non-Hodgkin's lymphomas by age group. (1997) (13)
Involvement of the bcl-6 gene in AIDS-related lymphomas. (1997) (12)
HCV inhibits antigen processing and presentation and induces oxidative stress response in gastric mucosa (2008) (12)
Primary effusion lymphoma: secretome analysis reveals novel candidate biomarkers with potential pathogenetic significance. (2014) (12)
Hodgkin's Disease: Old and Recent Clinical Concepts (1996) (11)
EBV-Associated Tumors: Pathogenetic Insights for Improved Disease Monitoring and Treatment (2005) (11)
Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis (2017) (11)
Nasopharyngeal lymphoid tissue masses in patients with human immunodeficiency virus‐1 (1995) (11)
Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours (2016) (11)
"Lipoleiomyoma with metaplastic cartilage" (benign mesenchymoma) of the uterine cervix. (1992) (11)
New transcriptional-based insights into the pathogenesis of desmoplastic small round cell tumors (DSRCTs) (2017) (11)
Clinical Behavior and Treatment Response of Epstein-Barr Virus-Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials. (2020) (11)
Prognostic factors in human herpesvirus 8-related lymphoproliferative disorders associated with HIV infection. (2006) (11)
Malignant lymphomas in patients with HIV infection. (1996) (11)
Immunohisto‐cytochemical correlation of DAP IV‐CD 26 reactivity with immunblogic markers of lymphocyte activation in human lymphoid tissues (1990) (10)
Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineage. (1993) (10)
Chemokine receptors as therapeutic tools in Hodgkin lymphoma: CCR4 and beyond. (2010) (10)
A novel bcl‐1/JH breakpoint from a patient affected by mantle cell lymphoma extends the major translocation cluster (2002) (10)
Primary Hodgkin's Disease of the Vagina (2000) (10)
Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphomas (2000) (10)
High frequency of CD45RO expression in AIDS-related B-cell non-Hodgkin's lymphomas. (1995) (9)
The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma. (2009) (9)
Report of an unusual small lymphocytic B‐cell lymphoma selectively involving the B‐zone of lymph node (1990) (9)
Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses. (2005) (9)
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection. (2005) (9)
TuBaFrost: European virtual tumor tissue banking. (2006) (9)
Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment. (2013) (8)
EGFR Amplification in Metastatic Colorectal Cancer. (2021) (8)
What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type? (2001) (8)
microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response (2016) (8)
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma (2012) (8)
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas (2021) (8)
HCV‐Related Immunocytoma and Type II Mixed Cryoglobulinemia‐Associated Autoantigens (2007) (8)
Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma (2019) (8)
JH6 Gene Usage among HCV-Associated MALT Lymphomas Harboring t(14;18) Translocation (2005) (8)
Genetic Markers in Sporadic Tumors (2008) (7)
The Pathologic Spectrum of Aids- Related Non-Hodgkin’s Lymphomas (1999) (7)
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma. (2015) (7)
Immunoglobulin and T cell receptor gene rearrangements and in situ immunophenotyping in lymphoproliferative disorders (2004) (7)
Early lesions in lymphomas of germinal centre B-cell derivation: evidence and hypotheses (2012) (7)
The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. (2013) (7)
A unique case of extranodal DLBCL sharing genetic abnormalities with a synchronous ileal lymphoma exhibiting immunoarchitectural features of in situ follicular lymphoma (2012) (7)
Extracavitary KSHV-positive Solid Lymphoma (2013) (7)
Hodgkin lymphoma classification: Are we at a crossroads? (2017) (7)
Anti-vimentin antibody reactivity with Reed-Sternberg cells of Hodgkin's disease (2005) (7)
KSHV/HHV8 Doesnʼt Play a Significant Role in the Development of Plasmablastic Lymphoma of the Oral Cavity (2008) (7)
HIV-associated Hodgkin's lymphoma. Antiapoptotic pathways and mechanisms for immune escape by tumor cells in the setting of improved immunity. (2007) (7)
Incidence of novel N‐glycosylation sites in the B‐cell receptor of lymphomas associated with immunodeficiency (2004) (7)
High frequency of Epstein-Barr virus latent membrane protein-1 expression in acquired immunodeficiency syndrome-related Ki-1 (CD30)-positive anaplastic large-cell lymphomas. Italian Cooperative Group on AIDS and Tumors. (1994) (6)
Teaching Digital Pathology: The International School of Digital Pathology and Proposed Syllabus (2017) (6)
An update on the diagnostic relevance of CD26 antigen expression in CD30 positive anaplastic large cell lymphomas. (1995) (6)
Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment (2019) (6)
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV‐infected patient (2018) (6)
CD75: A B‐cell marker which should not be forgotten in lymphocyte predominant Hodgkin lymphoma (2014) (6)
Cell-secreted signals shape lymphoma identity. (2015) (6)
Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines (2011) (6)
T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome. (1999) (6)
Gamma heavy chain disease associated with Hodgkin' disease. Clinical, pathologic, and immunologic features of one case (1990) (6)
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis. (2014) (6)
Reproducibility between messenger RNA real-time polymerase chain reaction and messenger RNA in situ hybridization in oropharyngeal squamous cell carcinoma patients. (2016) (5)
Pathogenesis of malignant lymphomas in intravenous drug-abuser, HIV-infected patients. (1990) (5)
Bright-field in situ hybridization detects gene alterations and viral infections useful for personalized management of cancer patients (2018) (5)
Therapeutic options for HIV-associated lymphomas (2010) (5)
The role of current and new discriminating markers in the immunodiagnosis of Hodgkin's disease and other phenotypically related lymphomas. (1996) (5)
Sieve-like areas in mature cystic teratomas of the ovary. A histochemical and immunohistochemical study of 7 cases. (1994) (5)
Immunophenotyping of non-Hodgkin lymphomas (2013) (5)
DEFINING THE BETTER ALGORITHM FOR THE ACCURATE IDENTIFICATION OF HPV STATUS AMONG OROPHARYNGEAL SQUAMOUS-CELL CARCINOMA . RESULTS FROM A PILOT STUDY (2015) (5)
Immunodeficiency-associated Hodgkin lymphoma (2021) (5)
MDM 2 Overexpression Does Not Account for Stabilization of Wild-Type p 53 Protein in Non-Hodgkin ’ s Lymphomas (2000) (5)
Multiple Gene Expression Analyses in Human Lymphoid Tissues by TaqMan Low-density Array Using Amplified RNA Isolated From Paraffin-Embedded Samples (2009) (4)
Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? (2004) (4)
Dermatofibroma: superficial fibrous proliferation with reactive histiocytes--a multiple immunostaining analysis. (1994) (4)
Malignant fibrous histiocytoma. (1993) (4)
Malignant tumors in patients with HIV infection. (1996) (4)
HIV-associated Hodgkins lymphoma. Antiapoptotic pathways and mechanisms for immune escape by tumor cells in the setting of improved immunity. (2007) (4)
Nodular lymphocyte predominant Hodgkin lymphoma may show a nodular pattern in which tumour cells do not invade the surrounding spaces (2013) (4)
MOLECULAR PROFILE OF EPSTEIN-BARR VIRUS INFECTION IN AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (1999) (3)
Expression of BCL-6 Protein and Cd138/Syndecan-1 as B-Cell Markers in Hodgkin'S Disease (1999) (3)
Dendritic reticulum cell-related immunostaining for laminin in follicular and diffuse B-cell lymphomas (2005) (3)
[The pathology spectrum of AIDS-related non-Hodgkin's lymphoma]. (1998) (3)
Dissecting primary resistance to anti-EGFRs in RAS and BRAF wt metastatic colorectal cancer (mCRC): A case-control study. (2017) (3)
A modified cytochemical method for DAP IV demonstration which enables simultaneous visualization of cell surface immunostaining. (1988) (3)
Co-expression of Epstein-Barr virus latent membrane protein and vimentin in “aggressive” histological subtypes of Hodgkin's disease (2005) (3)
Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas. (1989) (3)
Methods of Simultaneous Visualization of Cytoplasmic Enzyme Reactivity and Cell Surface Antigens (by Cytochemistry Combined with Immunocytochemistry) in Individual Hematopoietic and Lymphoid Cells (1988) (3)
Subclassifying peripheral T-cell lymphoma NOS. (2019) (3)
Genotypic and immunohistological demonstration of the progression of an unusual reactive-like B-cell lymphoproliferative disorder to a high grade diffuse lymphoma. (1995) (3)
Aids-Related Non-Hodgkin Lymphomas (1996) (2)
Dissecting primary resistance to anti-EGFRs in RAS and BRAF wt metastatic colorectal cancer (mCRC): A case-control study. (2017) (2)
An IELSG International Survey of Primary Effusion Lymphoma (PEL). (2004) (2)
Personalized therapeutic strategies in HER2-driven gastric cancer (2021) (2)
HIV-associated lymphomas (2018) (2)
Checkpoint blockade therapy resistance in Hodgkin's lymphoma (2018) (2)
Dacomitinib (Daco) induction therapy for locally advanced (LA) or metastatic penile squamous cell carcinoma (PSCC): An open label, single-arm, phase II study. (2017) (2)
Aberrant Methylation of SHP-1 (SH2-Containing Phosphatases 1) and SOCS-1 (Suppressor of Cytokine Signalling 1) Genes in Immunodeficiency-Related Lymphomas. (2006) (2)
Morphologic Patterns and Molecular Pathways of Aids-Related Head and Neck and other Systemic Lymphomas (1996) (2)
Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL). (2006) (2)
Classical Hodgkin lymphoma (2018) (2)
E1 Detection as Prognosticator in Human Papillomavirus-Positive Head and Neck Cancers (2016) (2)
Can Reed-Sternberg cells of classic Hodgkin's disease be considered B-cells? (1999) (2)
MICRORNA DETECTION IN TUMOR TISSUE BY IN SITU HYBRIDIZATION (2014) (2)
Positive Linear Relationship between Nucleophosmin Protein Expression and the Viral Load in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: A Possible Tool for Stratification of Patients (2023) (1)
In Situ Follicular Neoplasia (2018) (1)
Hodgkin's disease cell lines Expression of functional CD40 antigen on Reed-Sternberg cells and (2011) (1)
A HISTOGENETIC MODEL FOR HODGKIN'S DISEASE (HD) DEVELOPMENT IN HIV-POSITIVE (HIV+) AND HIV-NEGATIVE (HIV−) INDIVIDUALS (1999) (1)
Comparison of Fibroblast Growth-factor Receptor Gene Alterations at the DNA versus Messenger RNA Level in Advanced Urothelial Cancer: Insights for Clinical Research. (2017) (1)
Nodular sclerosis classical Hodgkin lymphoma (NScHL) (2018) (1)
Cells and Vascular Endothelial Growth Factor Deregulation Lymphoma Indicates Derivation from T Follicular Helper Gene Expression Analysis of Angioimmunoblastic (2007) (1)
Dacomitinib (Daco) induction therapy for locally-advanced (LA) or metastatic penile squamous cell carcinoma (PSCC): An open label, single-arm, phase 2 study (2017) (1)
Upregulation of RAS pathway to predict the risk of distant metastases in HPV + oropharynx cancer. (2015) (1)
Follicular dendritic cell in lymphomas of follicular origin (2019) (1)
GENETIC ALTERATIONS AND EXPRESSION STATUS OF BCL-6 IN AIDS-RELATED LYMPHOMAS: RELATIONSHIP WITH EBV INFECTION AND IDENTIFICATION OF DISTINCT MOLECULAR PATHWAYS IN AIDS-LYMPHOMAGENESIS (1997) (1)
Very high frequencies of leukaemia-initiating cells in precursor T-acute lymphoblastic leukaemia may be obscured by (2013) (1)
Current and potential use of pathological targets in the treatment of Hodgkin lymphoma (2018) (1)
Genome Wide-DNA Profiling of HIV-Related Non-Hodgkin Lymphomas: Implications for Disease Pathogenesis and Histogenesis. (2007) (1)
Immunohistochemical characterization of Ki-M6 monoclonal antibody in Bouin-fixed, paraffin-embedded sections of normal and neoplastic human tissues (2005) (1)
Can a specifically-aimed pathologic classification overcome the difficulties in defining HIV-associated lymphomas? (1995) (1)
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study (2016) (1)
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma (2018) (1)
Hepatitis-C Virus (Hcv)-Associated B-Cell Lymphoproliferative Disorders (1995) (1)
How immunologic and genetic biomarkers impact Hodgkin lymphoma classification, diagnosis, and management: a huge potential that yet needs to be exploited (2018) (1)
Histogenesis and Pathogenesis of Primary Breast Lymphoma. (2004) (1)
Prognostic impact of fibroblast growth-factor receptor (FGFR) gene alterations in patients with locally advanced or metastatic urothelial carcinoma (UC) receiving first-line, platinum-based chemotherapy (2017) (0)
AIDS-associated non-Hodgkin lymphoma Aberrant somatic hypermutation in multiple subtypes of (2013) (0)
Phenotypic and functional characteristics of AIDS-related lymphoma cell lines (1997) (0)
aggressive lymphoma 182 BENEFIT OF ANTI-VIRAL AND PNEUMOCYSTIS CARINII PROPHYLAXIS IN PATIENTS TREATED WITH R-CHOP (2008) (0)
Reactivity of an Anti NS3-HCV-Induced Autoantibody in HCV-Positive Gastric Tissue by 2D Gel Immunoblot. (2006) (0)
Infectious Agents and Cancer High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance (2007) (0)
Subject Index Vol. 95, 1996 (1996) (0)
Hepatitis-C virus infections and malignant lymphomas (1995) (0)
IMMUNOGLOBULIN MUTATION PATTERN AND PHENOTYPIC PROFILE IN AIDS‐RELATED DIFFUSE LARGE CELL LYMPHOMA: IMPLICATIONS FOR HISTOGENESIS: ABSTRACT 50 (2000) (0)
Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer (2016) (0)
HIV-related lymphomas (2022) (0)
Cytokine Expression in Benign and Malignant B-Cell Lymphoproliferation in the Course of Sjogrens-Syndrome (1994) (0)
Subject Index, Vol. 80, 1988 (1988) (0)
HIV-Associated Lymphoid Disorders (2019) (0)
HHV-8-related lymphoproliferative disorders during HIV infection: A monoinstitutional experience (2005) (0)
KSHV-Associated Lymphoid Disorders (2019) (0)
Follicular lymphomas of germinal center (B- or T-cell) origin (2018) (0)
Primary central nervous system lymphoma (2015) (0)
The role of RB2/p130 tumor suppressor gene and HIV-1 infection in the pathogenesis of AIDS-related lymphomas. (2001) (0)
G03Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area (2015) (0)
Expression of HHV-8 latency genes modulates the interactions between PEL cells and mesothelial cells (2002) (0)
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area. (2015) (0)
disorders Molecular histogenesis of posttransplantation lymphoproliferative (2011) (0)
T-cell/histiocyte rich large B-cell lymphoma (2018) (0)
Genomic aberrations aff ecting the outcome of immunodefi ciency-related diff use large B-cell lymphoma (2012) (0)
Author Correction: The landscape of d16HER2 splice variant expression across HER2-positive cancers (2020) (0)
Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production (2017) (0)
Clinica l Features and Outcome of Primary Ef fus ion Lymphoma in HIV-Infected Pat ients : A Single-Inst i tut ion Study (2003) (0)
Contents, Vol. 80, 1988 (1988) (0)
The Immunodiagnosis of Hodgkin's Disease (1996) (0)
Abstract B57: Comprehensive molecular characterization of acquired resistance to anti-EGFR monoclonal antibodies (MoAbs) in patients with metastatic colorectal cancer (mCRC) (2015) (0)
Gamma-herpesvirus-associated lymphomas in the setting of HIV infection (2017) (0)
Classification of B-Cell Lymphomas and Immunodeficiency-Related Lymphoproliferations: What’s New? (2023) (0)
MIF/CD74 axis is a target for novel therapies in colon carcinomatosis (2017) (0)
Short Communication Demonstration ofaUnique Epstein-Barr Virus-Positive Cellular CloneinMetachronous Multiple Localizations ofHodgkin's Disease (1993) (0)
Lymphoid and non-lymphoid cell microenvironment of lymphoid follicles (2015) (0)
WT1 function in ovarian tumorigenesis: Possible role of WT1/p53 interaction (1994) (0)
THE STATUS OF BCL-6, CD138/SYNDECAN-1, LMP-1 AND BCL-2 IDENTIFIES DISTINCT CATEGORIES OF AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: PATHOGENETIC AND HISTOGENETIC IMPLICATIONS. (1998) (0)
560 Receptor Tyrosine Kinase Profiles and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma (2012) (0)
Author Correction: The landscape of d16HER2 splice variant expression across HER2-positive cancers (2020) (0)
Nodular lymphocyte-predominant Hodgkin lymphoma (2018) (0)
LIPOEIOMYOMA WITH METAPLASTIC CARTILAGE (BENIGH MESENCHYMOMA) OF THE UTERINE CERVIX. AUTHOR'S REPLY (1992) (0)
Lymphomas Harboring t(14;18) Translocation Gene Usage among HCV-Associated MALT 6 H J (2011) (0)
Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas (2008) (0)
Classification of Hodgkin lymphoma over years (2018) (0)
Editor's/Publisher's Disclaimer (1998) (0)
Lymphomas in People Living with HIV (2022) (0)
Detection of bcl-2 gene rearrangement in MALT lymphomas from HCV-infected patients (2004) (0)
Tumor microenvironment contribution to checkpoint blockade therapy. Lessons learned from Hodgkin lymphoma. (2023) (0)
Lymphocyte-rich classical Hodgkin lymphoma (2018) (0)
CRUCIAL, BUT STILL POORLY KNOWN, KEY POINTS REGARDING DESIGN AND CONSTRUCTION OF TMA (2015) (0)
Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 2 (2020) (0)
Infection of neoplastic B cells by HCV in low-grade non-Hodgkin's lymphomas associated with type II mixed cryoglobulinemia. (1999) (0)
The American College of Surgeons Commission on Cancer and the American Cancer Society PEL and HHV 8-Unrelated Effusion Lymphomas Classification and Diagnosis (2008) (0)
Intrafollicular neoplasia/in situ lymphoma (2013) (0)
Clinical F eatures a nd O utcome o f P rimary E ffusion L ymphoma in H IV-Infected P atients: A S ingle-Instituti on S tudy (2003) (0)
Molecular Analysis of Immunoglobulin Variable Genes in HIV-Related Non-Hodgkin Lymphoma: Implications for Disease Pathogenesis and Histogenesis. (2005) (0)
Fig 1. Cd138/b-b4 Expression in Aids-related Extranodal Nhls with Plasma Cell Differentiation. (a) Hhv-8 Role of Mast Cell and Stem Cell Factor in Hyperpigmented Mycosis Fungoides (1997) (0)
TranslocationMALT Lymphomas Harboring t(14;18) Gene Usage among HCV-Associated 6HJ (2005) (0)
Amplification of the Vdj (Variable, Diversity and Joining) Region of Heavy Chains of Immunoglobulins for the Determination of B-Cell Clonality in the Case of Lymphoproliferative Disease with Known Immunogenotype (1993) (0)
Abstract B19: Disruption of energy homeostasis as an approach to block the proliferation of colon carcinomatosis (2017) (0)
Abstract LB-238: Dissecting primary resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) inRASandBRAFwild-type (wt) metastatic colorectal cancer (mCRC) (2017) (0)
AND FLIPI ARE NOT APPLICABLE IN PATIENTS WITH MALT LYMPHOMA (2008) (0)
[Recent insights on the pathogenesis of non-Hodgkin's lymphoma]. (1995) (0)
The landscape of d16HER2 splice variant expression across HER2-positive cancers (2019) (0)
Plasmablastic Lymphoma (2019) (0)
Immunohistochemical detection of carcinoembryonic antigen in infiltrating duct carcinomas of the breast: correlation with morphofunctional parameters and prognostic significance. (1986) (0)
Suitability of mRNA ISH assay for the detection of HPV infection in oropharyngeal squamous cell carcinoma (OSCC) patients: a preliminary evidence (2016) (0)
Lymphocyte depletion classical Hodgkin lymphoma (2018) (0)
Malignancies of Myeloid and Lymphoid Origin CD30 Ligand Is Frequently Expressed in Human Hematopoietic (2013) (0)
Abstract CT139: First-line therapy with dacomitinib, an orally available pan-her tyrosine kinase inhibitor, for locally-advanced or metastatic penile squamous cell carcinoma: Results of an open label, single-arm, single-center, phase 2 study (2017) (0)
Immunohistochemical analysis of CEA in colorectal adenomas with and without early cancer. (1987) (0)
Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature. (2007) (0)
Primary Effusion Lymphoma (PEL) (2019) (0)
Translocation MALT Lymphomas Harboring t ( 14 ; 18 ) Gene Usage among HCV-Associated 6 HJ (2005) (0)
Author ' s response to reviews Small primary adenocarcinoma in adenomyosis with nodal metastasis : a case report (2007) (0)
Gene Usage among HCV-Associated 6 H J (2017) (0)
Contents, Vol. 95, 1996 (1996) (0)
[Primary effusion lymphoma and other lymphoproliferative diseases associated with HHV-8]. (2000) (0)
Mixed cellularity classical Hodgkin lymphoma (MCcHL) (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Annunziata Gloghini?

Annunziata Gloghini is affiliated with the following schools:

Annunziata Gloghini's Academic­Influence.com Rankings

Annunziata Gloghini's Degrees

Why Is Annunziata Gloghini Influential?

Annunziata Gloghini's Published Works

Published Works

What Schools Are Affiliated With Annunziata Gloghini?

Annunziata Gloghini's AcademicInfluence.com Rankings